Feedback / Questions
Imfinzi (durvalumab) - AstraZeneca, Celgene
Imfinzi: P2 data from P1/2 BEGONIA trial (NCT03742102) for 1L metastatic TNBC in H2 2020
(AstraZeneca)
-
Oct 24, 2019 -
Q3 2019 Results: Data from P1/2 STUDY 1108 (NCT01693562) in advanced solid tumors in H2 2019
P1/2 data • P2 data
https://www.astrazeneca.com/content/dam/az/PDF/2019/q3/Year-to-date_and_Q3_2019_Results_clinical_trials_appendix.pdf
Oct 24, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious